Literature DB >> 2843290

A movable and regulable inactivation function within the steroid binding domain of the glucocorticoid receptor.

D Picard1, S J Salser, K R Yamamoto.   

Abstract

The glucocorticoid receptor is a signal transducer that interacts both with the signal and with the genes it regulates. We showed previously that nuclear localization of the receptor requires hormone binding. We have now constructed recombinant receptors that relieve hormonal control of nuclear localization, and we demonstrate that the DNA binding/transcriptional regulatory functions of the receptor are also regulated directly by hormone. Surprisingly, regulation by the steroid binding domain appears to be relatively independent of protein structure. For example, regulation is maintained when the steroid binding region is repositioned from the C-terminus to the N-terminus of the receptor. Furthermore, the activity of an unrelated protein, the adenovirus E1A gene product, becomes hormone regulated upon fusion to the steroid binding domain. We speculate that the inhibitory effect of the unliganded steroid binding domain may be mediated by heat shock protein hsp90, which binds selectively to the unliganded receptor.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2843290     DOI: 10.1016/0092-8674(88)90122-5

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  120 in total

1.  CDC25A phosphatase is a target of E2F and is required for efficient E2F-induced S phase.

Authors:  E Vigo; H Müller; E Prosperini; G Hateboer; P Cartwright; M C Moroni; K Helin
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

2.  A ligand-reversible dimerization system for controlling protein-protein interactions.

Authors:  C T Rollins; V M Rivera; D N Woolfson; T Keenan; M Hatada; S E Adams; L J Andrade; D Yaeger; M R van Schravendijk; D A Holt; M Gilman; T Clackson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

3.  Nuclear localization of NPR1 is required for activation of PR gene expression.

Authors:  M Kinkema; W Fan; X Dong
Journal:  Plant Cell       Date:  2000-12       Impact factor: 11.277

4.  Intranuclear localization of human papillomavirus 16 E7 during transformation and preferential binding of E7 to the Rb family member p130.

Authors:  K Smith-McCune; D Kalman; C Robbins; S Shivakumar; L Yuschenkoff; J M Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

Review 5.  Chemically regulated expression systems and their applications in transgenic plants.

Authors:  Renhou Wang; Xiaofu Zhou; Xingzhi Wang
Journal:  Transgenic Res       Date:  2003-10       Impact factor: 2.788

6.  Hoxa9 and Meis1 are key targets for MLL-ENL-mediated cellular immortalization.

Authors:  Bernd B Zeisig; Tom Milne; María-Paz García-Cuéllar; Silke Schreiner; Mary-Ellen Martin; Uta Fuchs; Arndt Borkhardt; Sumit K Chanda; John Walker; Richard Soden; Jay L Hess; Robert K Slany
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

7.  An ochre mutation in the vitamin D receptor gene causes hereditary 1,25-dihydroxyvitamin D3-resistant rickets in three families.

Authors:  H H Ritchie; M R Hughes; E T Thompson; P J Malloy; Z Hochberg; D Feldman; J W Pike; B W O'Malley
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

8.  Fusion of adenovirus E1A to the glucocorticoid receptor by high-resolution deletion cloning creates a hormonally inducible viral transactivator.

Authors:  D M Becker; S M Hollenberg; R P Ricciardi
Journal:  Mol Cell Biol       Date:  1989-09       Impact factor: 4.272

9.  The molecular chaperone Hsp90 can negatively regulate the activity of a glucocorticosteroid-dependent promoter.

Authors:  K I Kang; X Meng; J Devin-Leclerc; I Bouhouche; A Chadli; F Cadepond; E E Baulieu; M G Catelli
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

10.  A mutation of the glucocorticoid receptor in primary cortisol resistance.

Authors:  D M Malchoff; A Brufsky; G Reardon; P McDermott; E C Javier; C H Bergh; D Rowe; C D Malchoff
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.